Latest market price
74.19
-0.49-0.66%
ASHQT63Ashland Inc.·NYSE
74.19-0.66%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E65.65EPS (ttm)1.13Insider Own1.57%Shs Outstand45.79MPerf Week2.59%
Market Cap3.40BForward P/E15.00EPS next Y4.95Insider Trans0.00%Shs Float37.78MPerf Month6.72%
Enterprise Value4.42BPEG4.48EPS next Q1.27Short Float13.43%Perf Quarter2.59%
Income52.00MP/S1.84EPS this Y22.79%Short Ratio7.50Perf Half Y41.21%
Sales1.84BP/B1.82EPS next Y15.08%ROA1.14%Short Interest5.07MPerf YTD26.45%
Book/sh40.84P/C7.72EPS next 5Y14.66%ROE2.77%52W High78.25 -5.19%Perf Year52.43%
Cash/sh9.61P/FCF10.52EPS past 3/5Y—ROIC1.94%52W Low47.12 57.45%Perf 3Y-2.16%
Dividend Est.1.68 (2.26%)EV/EBITDA11.62Sales past 3/5Y-8.63% -1.98%Gross Margin29.35%Volatility2.05% 2.21%Perf 5Y-23.67%
Dividend TTM1.67 (2.25%)EV/Sales2.40EPS Y/Y TTM—Oper. Margin7.33%ATR (14)1.65Perf 10Y35.53%
Dividend Ex-DateSep 01, 2026Quick Ratio1.89Sales Y/Y TTM-1.39%Profit Margin2.82%RSI (14)62.65Recom2.36
Dividend Gr. 3/5Y8.13% 8.45%Current Ratio3.05EPS Q/Q-8.08%SMA202.83%Beta0.36Target Price77.88
Payout146.15%Debt/Eq0.78Sales Q/Q7.34%SMA503.76%Rel Volume1.07Prev Close74.68
Employees2,900LT Debt/Eq0.78EarningsNov 03SMA20016.31%Avg Volume597.64KPrice74.19
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.-4.99% -0.74%Net Debt/EBITDA2.68Volume638,683Change-0.66%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-16-26ReiteratedWells FargoEqual Weight$70 → $75
Oct-05-26ReiteratedUBSBuy$83 → $80
Aug-06-26ReiteratedMorgan StanleyEqual Weight$58 → $78
Jul-31-26ReiteratedDeutsche BankBuy$74 → $85
Jul-30-26ReiteratedUBSBuy$72 → $83
Jul-29-26ReiteratedBMO CapitalOutperform$71 → $75
Jul-29-26ReiteratedMizuhoOutperform$70 → $77
Jul-27-26ReiteratedWolfe Research$110 → $78
Jun-10-26ReiteratedUBSBuy$73 → $72
May-06-26UpgradeSeaport GlobalNeutral → Buy$75
Latest News· Times ET
Oct-27-26
Oct-21-26
Oct-03-26
Sep-29-26
Sep-24-26
Sep-22-26
Sep-18-26
Sep-16-26
Sep-15-26
Sep-14-26
Company

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
9/30/2025
FY 2024
9/30/2024
FY 2023
9/30/2023
FY 2022
9/30/2022
FY 2021
9/30/2021
FY 2020
9/30/2020
FY 2019
9/30/2019
FY 2018
9/30/2018
Total Revenue1,8431,8242,1132,191—————
Cost of Goods Sold Incl. D&A1,3021,2751,4951,523—————
Gross Profit541549618668—————
Selling, General and Administrative Excl. Other324345404365—————
Research and Development55545551—————
Other Operating Expense2792518580—————
Operating Income135-775-26172—————
Interest Expense61635357—————
Unusual Expense
—————————
Non-Operating Income (Expense)51295545—————
Net Income Before Taxes125-809-24160—————
Income Taxes5013-223-8—————
Consolidated Net Income52-845169178—————
Net Income From Continuing Operations75-822199168—————
Net Income52-845169178—————
EPS (Recurring)1.14-18.373.453.36—————
EPS (Basic, Before Extraordinaries)1.14-18.373.453.36—————
EPS (Diluted)1.13-18.373.383.31—————
EBITDA380-509303457—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio65.65—25.7324.68—————
Price To Sales Ratio1.851.212.021.98—————
Gross Margin29.3530.1029.2530.49—————
Operating Margin7.33-42.49-1.237.85—————
Net Margin2.82-46.338.008.12—————
Shares Outstanding46464953—————
Market Capitalization3,4132,2044,2624,329—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$80.79$71.38$61.97$52.56$43.15● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MUSA OSAMA MSVP and CTOSep 21 '26Option Exercise69.0610,418719,46741,224Sep 23
LAMPKIN ROBIN E.SVP, GC & SecretaryAug 11 '26Option Exercise37.293,612134,6916,825Aug 12
MUSA OSAMA MSVP and CTOJul 29 '26Option Exercise57.9611,060641,03730,806Jul 30
Assis Alessandra FaccinSVP and GM, Life SciencesJul 27 '26Option Exercise66.383,215213,4129,099Jul 29
MINICUCCI JAMES P.SVP and GM, Personal CareMay 08 '26Option Exercise55.014,310237,0938,567May 11
Kulkarni Ashish KDirectorJan 21 '26Option Exercise0.004,22602,113Jan 22
NOVO GUILLERMOChair of the Board and CEONov 17 '25Option Exercise49.606,122303,651143,412Nov 19
Drury EileenSVP and Chief HRONov 17 '25Option Exercise49.6056728,1237,881Nov 19
MUSA OSAMA MSVP and CTONov 17 '25Option Exercise49.6097648,41029,875Nov 19
RICHARDSON SAMUELVP, Controller and PAONov 17 '25Option Exercise49.601075,3071,104Nov 19
WHITAKER WILLIAMSVP, CFO & PFONov 17 '25Option Exercise49.601075,3072,082Nov 19
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 17 '25Option Exercise49.6023911,8545,095Nov 19
MUSA OSAMA MSVP and CTONov 14 '25Option Exercise51.512,091107,70729,616Nov 19
MUSA OSAMA MSVP and CTONov 13 '25Option Exercise53.101,39373,96828,002Nov 19
LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty.Nov 14 '25Option Exercise51.511,27665,7275,237Nov 17
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.